Latest Period
Q2 2026
Security Snapshot
CG Oncology, Inc. - Common Stock, par value $0.0001 (CGON) Institutional Ownership
CUSIP: 156944100
13F Institutional Holders and Ownership History from Q1 2024 to Q2 2026
Institutions Reporting
228
Shares (Excl. Options)
93,822,904
Price
$71.05
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001
- Symbol
- CGON on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 93,822,904
- Total 13F value
- $6,662,948,092
- Portfolio coverage rank
- 0.02%
- Share change
- +5,495,167
- Value change
- +$403,011,888
- Number of holders
- 228
- Shares outstanding
- 87,881,102
- SEC-reported price per share
- $76.99
- Insider filing price
- $76.99
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CGON - CG Oncology, Inc. - Common Stock, par value $0.0001 is tracked under CUSIP 156944100.
- 228 institutions reported positions in Q2 2026.
- 12 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 233 to 228 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $5,928,391,800 to $6,662,948,092.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 228 institutions filings for Q2 2026.
Security key
156944100
Latest holder period
Q2 2026
13F holders
228
13D/G owners
12
CIK / CUSIP context first
Open Q2 2026 holders
CGON full holder history
CG Oncology, Inc. SEC filings
CG Oncology, Inc. company facts
CG Oncology, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 156944100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
12
Security
CGON
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.7% | +18% | $594,318,382 | +$106,778,784 | 8,514,590 | +22% | RTW Investments, LP | 30 Jun 2026 |
| T. Rowe Price Investment Management, Inc. | 8% | $454,970,335 | 6,720,389 | T. Rowe Price Investment Management, Inc. | 31 Mar 2026 | |||
| Decheng Capital Global Life Sciences Fund IV, L.P. | 8.4% | $178,215,582 | 6,371,669 | Xiangmin Cui | 31 Dec 2024 | |||
| BlackRock, Inc. | 6.8% | $427,983,601 | 6,023,696 | BlackRock, Inc. | 30 Jun 2026 | |||
| WELLINGTON MANAGEMENT GROUP LLP | 6% | -17% | $371,667,620 | -$13,124,354 | 5,324,751 | -3.4% | Wellington Management Group LLP | 30 Jun 2026 |
| Longitude Capital Partners IV, LLC | 6% | $121,032,477 | 4,662,268 | Patrick G. Enright | 11 Sep 2025 | |||
| Foresite Capital Fund V, L.P. | 4.9% | $300,570,945 | 4,306,174 | James B. Tananbaum | 30 Jun 2026 | |||
| Unique Diamond Investments Ltd | 5.5% | $117,791,208 | 4,211,341 | SONG, Hong Fang | 31 Dec 2024 | |||
| FMR LLC | 5.1% | $100,262,786 | 3,856,261 | FMR LLC | 30 Jun 2025 | |||
| TCG Crossover GP I, LLC | 4.8% | $102,655,662 | 3,670,206 | TCG Crossover GP I, LLC | 31 Mar 2025 | |||
| Seven Fleet Capital Management LP | 2% | $62,145,313 | 1,542,833 | Brian Liu | 06 Oct 2025 | |||
| Seven Fleet Partners LP | 1.9% | $39,333,320 | 1,515,151 | Seven Fleet Partners LP | 11 Sep 2025 |
As of 30 Jun 2026, 228 institutional investors reported holding 93,822,904 shares of CG Oncology, Inc. - Common Stock, par value $0.0001 (CGON). This represents 107% of the company’s total 87,881,102 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
85%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.7% | 8,514,590 | +22% | 5.2% | $604,961,620 |
| T. Rowe Price Investment Management, Inc. | 7.5% | 6,616,899 | -1.5% | 0.31% | $470,131,000 |
| Decheng Capital LLC | 7.3% | 6,371,669 | 0% | 62% | $452,707,083 |
| BlackRock, Inc. | 7.1% | 6,256,288 | +24% | 0.01% | $444,509,264 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.1% | 5,324,751 | -0.87% | 0.07% | $378,323,559 |
| FMR LLC | 4.7% | 4,161,493 | +11% | 0.01% | $295,674,077 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.3% | 3,805,010 | +4.2% | 0.03% | $270,347,000 |
| TCG Crossover Management, LLC | 4.2% | 3,670,206 | 0% | 6.3% | $260,768,136 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.9% | 3,465,197 | +12% | 0.01% | $246,202,247 |
| STATE STREET CORP | 3.9% | 3,437,590 | +30% | 0.01% | $244,240,770 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 3,316,793 | +9.3% | 0.01% | $235,658,143 |
| Foresite Capital Management VI LLC | 2.7% | 2,369,574 | +6.7% | 26% | $168,358,233 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 2,153,277 | +35% | 0.01% | $153,018,831 |
| Seven Fleet Capital Management LP | 2.1% | 1,886,236 | +2390% | 22% | $134,017,068 |
| EcoR1 Capital, LLC | 1.7% | 1,494,300 | +36% | 5.3% | $106,170,015 |
| DV Trading LLC | 1.6% | 1,439,393 | 0% | 8.5% | $102,268,873 |
| Avidity Partners Management LP | 1.6% | 1,398,948 | +8.5% | 16% | $99,395,255 |
| ALLIANCEBERNSTEIN L.P. | 1.6% | 1,374,149 | +6.5% | 0.03% | $93,002,404 |
| FRANKLIN RESOURCES INC | 1.5% | 1,312,880 | -13% | 0.02% | $93,280,138 |
| MORGAN STANLEY | 1.3% | 1,177,109 | +126% | 0% | $83,633,662 |
| ACORN CAPITAL ADVISORS, LLC | 1.3% | 1,131,500 | +0.09% | 22% | $80,393,115 |
| Foresite Capital Management V, LLC | 1.2% | 1,079,050 | +7.5% | 21% | $76,666,503 |
| Logos Global Management LP | 1.1% | 1,000,000 | +74% | 3.1% | $71,050,000 |
| BANK OF AMERICA CORP /DE/ | 1.1% | 984,918 | -32% | 0% | $69,978,424 |
| UBS Group AG | 1.1% | 977,695 | -25% | 0.01% | $69,465,230 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 93,822,904 | $6,662,948,092 | +$403,011,888 | $71.05 | 228 |
| 2026 Q1 | 88,132,565 | $5,928,391,800 | +$431,702,680 | $67.68 | 233 |
| 2025 Q4 | 82,634,336 | $3,430,451,436 | +$57,920,734 | $41.52 | 195 |
| 2025 Q3 | 77,648,888 | $3,127,517,509 | +$92,134,469 | $40.28 | 175 |
| 2025 Q2 | 75,914,566 | $1,973,784,426 | +$139,061,983 | $26.00 | 161 |
| 2025 Q1 | 70,762,639 | $1,735,652,621 | +$98,334,837 | $24.49 | 141 |
| 2024 Q4 | 66,057,386 | $1,894,540,823 | +$282,964,154 | $28.68 | 137 |
| 2024 Q3 | 52,183,069 | $1,962,909,867 | +$277,213,171 | $37.73 | 120 |
| 2024 Q2 | 43,274,514 | $1,366,161,770 | +$105,145,067 | $31.57 | 109 |
| 2024 Q1 | 38,771,794 | $1,702,050,758 | +$1,700,470,138 | $43.90 | 96 |